FINWIRES · TerminalLIVE
FINWIRES

Aptose Biosciences Says Acquisition by Hanmi Delayed Until June

By

Aptose Biosciences' (APS.TO) acquisition by Hanmi has been further delayed as certain Korean regulatory approvals remain in progress, the company said on Friday.

The parties do not anticipate that the review will prevent closing and are working toward completing the arrangement in June, a statement said.

The company has received an additional advance of US$2.0 million from Hanmi as part of a US$11.9 million loan amended facility agreement announced last year. To date, Aptose has received US$9.9 million. The funds enable uninterrupted continuance of the Tuscany clinical trial with tuspetinib in combination with venetoclax and azacitidine for the frontline treatment of newly diagnosed acute myeloid leukemia (AML).

Aptose shares closed unchanged at $2.28 on Thursday on the Toronto Stock Exchange.

Related Articles

Mining & Metals

South Bow Secures 20-Year Binding Commitments During Open Season

South Bow (SOBO.TO) secured 20-year binding commitments during its open season for firm transportation service from Hardisty, Alberta, to U.S. delivery points, the company said Friday.The development represents a milestone for South Bow's Prairie Connector project and underscores the need for market access for Western Canadian crude oil, the company said.The project includes the construction of about 380 kilometers of 36-inch pipeline and associated facilities, as well as the use of about 150 km of previously installed and preserved 36-inch pipeline and two pump stations.The pipeline would extend from Hardisty to the Canada-U.S. border, where it would connect to Bridger Pipeline's downstream facilities.South Bow aims to make a final investment decision for the project in mid-2027.

$SOBO.TO
Mining & Metals

Mundoro Capital Q1 Fee Income Edges Down, Jim Scott Returns as CFO

Mundoro Capital (MUN.V) on Friday said fee income for the first quarter dipped slightly, and also announced a new chief financial officer appointment.Mundoro Capital earned $0.7 million in fee income for the quarter ended March 31, 2026, a slight decrease from the $0.74 million in fee income for the prior year period. The decrease was due to lower option fee and operator fee income as well as a lower exchange rate.The company advanced exploration areas primarily in Eastern Serbia, within the Timok Magmatic Complex (TMC), known for copper-gold deposits during the quarter. The area benefits from established infrastructure including well-serviced roads and grid power. Mundoro's licenses in this region are optioned to a BHP Group subsidiary.Mundoro has appointed Jim Scott as its chief financial officer. Scott previously held the position from June 2022 to January 2025. He takes over from Mireia Cervera Medina, who is stepping down effective July 6.Mundoro Capital shares closed down $0.015, to $0.425, on Thursday on the TSX Venture Exchange.

$MUN.V
Mining & Metals

Stria Lithium Provides Update on Proposed Royalty and Change of Business Transaction

Stria Lithium (SRA.V) continues to advance the various components needed under TSX Venture Exchange (TSXV) Policy 5.2 - Changes of Business and Reverse Takeovers, regarding the proposed acquisition of a net smelter return royalty of up to 2% on the advanced West Australian Mt Henry Gold Project pursuant to an investment agreement with Alicanto Minerals (ASX: AQI), it said on Friday.Work related to the acquisition, including technical reporting, preparation of a listing statement, preparation of transaction documentation, and assembly of required regulatory filings, is progressing as expected, it said.Stria will hold an annual and special meeting of shareholders on June 9 to elect the directors of the company that will hold office until the next general meeting of the company or completion of the acquisition and approve the change of name of the company to Arc Mineral Royalties Ltd.The company's shares last traded April 8, closing at $0.78 on the TSXV.

$SRA.V